MED17.11 - Mouse DRG Cell Line with Properties of Nociceptors

MED17.11 cells have the potential to replace or reduce the use of primary DRG culture.
Technology No.
Med17.11
1
Med17.11
2

A DRG progenitor cell line from the Immortomouse.

MED17.11 cells have the potential to replace or reduce the use of primary DRG culture in sensory, pain and developmental research by providing a simple model to study neurite outgrowth, the developmental specification and peripheral sensitisation of DRG neurons.

For academic licences we charge a £200 packaging fee and request that licensees arrange for delivery.  Recipients are responsible for paying any import duties that are incurred.

  • swap_vertical_circlemode_editAuthors (1)
    Dr Mohammed Nassar
  • swap_vertical_circlelibrary_booksReferences (1)
    1. Nassar, Drundy, Holley, Chetrit, Doran (2015), Mouse DRG Cell Line with Properties of Nociceptors, Plos One
  • swap_vertical_circlecloud_downloadSupporting documents (0)
    Additional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
Non-Commercial/Academic - Med17.11 (with Fed-Ex account)
Select this option if you are arranging for your courier to collect the materials (£200 charge)

Term: perpetual

Price per unit:
£0.00 excl. VAT

Non-Commercial/Academic - med17.11 (without Fed-Ex account)
Select this option if Sheffield is arranging for delivery (£320 charge)

Term: perpetual

Price per unit:
£0.00 excl. VAT

Commercial Licence - Med 17.11
6-month trial licence for commercial organisations

Term: 6 months

Price per unit:
£5,000.00 excl. VAT

Commercial Licence - Med 17.11
perpetual licence for commercial organisations

Term: perpetual

Price per unit:
£20,000.00 excl. VAT